| Business Summary | | Biacore
International
AB
develops,
manufactures
and
markets
analytical
instruments
that
employ
affinity-based
biosensor
technology.
This
technology
utilizes
optical
measurement
based
on
the
phenomenon
of
surface
plasmon
resonance
for
determining
the
binding
properties
of
biomolecules
and
their
concentration
in
a
sample.
The
instruments
are
primarily
used
for
basic
life
science
research
and
drug
discovery,
and
the
main
customer
groups
are
medical
and
life
science
research
laboratories
within
the
pharmaceutical
industry,
universities
and
research
institutes.
Biacore's
technology
can
also
be
applied
in
other
areas
such
as
food
and
environmental
control.
Biacore's
products
provide
researchers
in
industrial
and
academic
settings
with
tools
to
extend
their
knowledge
about
biological
processes,
and
to
put
this
knowledge
to
use
in
applied
research
and
development. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | BCOR
manufactures
and
markets
analytical
instruments
that
employ
affinity-based
biosensor
technology
used
for
monitoring
biomolecular
interactions.
For
the
six
months
ended
6/30/01,
revenues
rose
37%
to
SEK254.9
million.
Net
income
rose
17%
to
SEK23M.
Revenues
reflect
strong
growth
in
the
sales
of
the
Biacore
3000
system.
Net
income
was
partially
offset
by
an
increase
in
marketing
and
sales
costs,
research
and
development
expenditures
and
administration
expenses. | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | Lars-Goran Andren, 57 | Chairman,
CEO | Ulf Jonsson, 47 | Pres,
Director | Lars-Olov Forslund, 48 | Exec.
VP and CFO | Anders Svenberg, 44 | VP
of HR |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|